Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find Radio Compass News for AM20061770

    Client Email Product

    AM20061770

    APIs // Active Pharmaceutical Ingredients

    PRICE INFORMATION

    INTERMEDIATES

    DOSSIERs // Finished Dosage Formulations

    DRUG PRODUCT COMPOSITION

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS

    ANALYTICAL SOLUTION(s)

    DIGITAL CONTENT

    PharmaCompass
    Product SearchProduct Search
    API SUPPLIERS
    API Suppliers

    API Suppliers

    44
    US DMFs Filed

    US DMFs Filed

    26
    CEP/COS Certifications

    CEP/COS Certifications

    9
    JDMFs Filed

    JDMFs Filed

    11
    Other Certificates

    Other Certificates

    18
    Other Suppliers

    Other Suppliers

    12
    API REF. PRICE (USD / KG)
    395

    API Market Place

    11
    INTERMEDIATES
    3
    DOSSIERS // FDF
    USA (Orange Book)

    USA (Orange Book)

    77
    Europe

    Europe

    24
    Canada

    Canada

    15
    Australia

    Australia

    0

    South Africa

    South Africa

    2
    Uploaded Dossiers

    Uploaded Dossiers

    32
    GLOBAL SALES (USD Million)

    U.S. Medicaid

    634.00

    Annual Reports

    0

    FDF Market Place

    1
    EXCIPIENTS
    266
    PATENTS & EXCLUSIVITIES

    USFDA Orange Book Patents

    36

    USFDA Exclusivities

    0

    DIGITAL CONTENT

    Blog #PharmaFlow

    3

    News

    17
    REF STANDARD

    EDQM

    2

    USP

    2

    JP

    6

    Other Listed Suppliers

    1
    SERVICES
    1
    left grey arrow
    right gray arrow
    • TABLET;ORAL - EQ 15MG BASE
    • TABLET;ORAL - EQ 30MG BASE
    • TABLET;ORAL - EQ 45MG BASE
    • TABLET;ORAL - 500MG;EQ 15MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
    • TABLET;ORAL - 850MG;EQ 15MG BASE
    • TABLET, EXTENDED RELEASE;ORAL - 1GM;EQ 15MG BASE
    • TABLET, EXTENDED RELEASE;ORAL - 1GM;EQ 30MG BASE
    Full View ScreenFull Screen View
    Macleods Pharma USA Inc recalls 31,968 bottles of diabetes drug in US
    Macleods Pharma USA Inc recalls 31,968 bottles of diabetes drug in US

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/macleods-pharma-usa-inc-recalls-31968-bottles-of-diabetes-drug-in-us/articleshow/71791308.cms

    ECONOMICTIMES
    28 Oct 2019
    Share Share
    Enforcement Report - Week of October 23, 2019
    Enforcement Report - Week of October 23, 2019

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-october-23-2019-1571893469.pdf

    FDA
    24 Oct 2019
    Share Share
    Prinston Pharma’s Generic Pioglitazone Hydrochloride Receives Approval In US
    Prinston Pharma’s Generic Pioglitazone Hydrochloride Receives Approval In US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207806

    FDA
    20 Apr 2018
    Share Share
    PuraCap's Generic Pioglitazone Hydrochloride Receives Approval In US
    PuraCap's Generic Pioglitazone Hydrochloride Receives Approval In US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206738

    11 Oct 2017
    Share Share
    Nesina®, Kazano®, & Oseni® : Takeda Pharmaceutical V. Torrent Pharmaceuticals
    Nesina®, Kazano®, & Oseni® : Takeda Pharmaceutical V. Torrent Pharmaceuticals

    http://www.myepique.com/pdf/takedatorrent.pdf

    PATENT LITIGATION
    05 May 2017
    Share Share
    Generic oral antidiabetic lot EMS is suspended
    Generic oral antidiabetic lot EMS is suspended

    https://www.pharmacompass.com/pdf/news/generic-oral-antidiabetic-lot-ems-is-suspended-1478086818.pdf

    ANVISA
    01 Nov 2016
    Share Share
    NEJM study finds Actos holds off repeat strokes in insulin-resistant patients
    NEJM study finds Actos holds off repeat strokes in insulin-resistant patients

    http://www.fiercepharma.com/story/nejm-study-finds-actos-holds-repeat-strokes-heart-attacks-insulin-resistant/2016-02-18

    Tracy Staton FIERCE PHARMA
    18 Feb 2016
    Share Share
    In Japan, fast approvals, more R&D cash and price cuts ahead
    In Japan, fast approvals, more R&D cash and price cuts ahead

    http://www.fiercepharmaasia.com/story/japan-fast-approvals-more-rd-cash-and-price-cuts-ahead/2016-01-14

    EJ Lane FIERCE PHARMA ASIA
    14 Jan 2016
    Share Share
    Takeda revs R&D dealmaking engine again with NsGene deal on Parkinson's device
    Takeda revs R&D dealmaking engine again with NsGene deal on Parkinson's device

    http://www.fiercepharmaasia.com/story/takeda-revs-rd-dealmaking-engine-again-nsgene-deal-parkinsons-device/2016-01-08

    EJ Lane FIERCE PHARMA ASIA
    09 Jan 2016
    Share Share
    Macleods` Generic Pioglitazone HCL & Metformin HCL approved in US for diabetes
    Macleods` Generic Pioglitazone HCL & Metformin HCL approved in US for diabetes

    https://www.pharmacompass.com/pdf/news/macleods-generic-pioglitazone-hcl-metformin-hcl-approved-in-us-for-diabetes-1447145414.pdf

    FDA
    07 Nov 2015
    Share Share
    Takeda's $2.37 Billion Actos Settlement goes through
    Takeda's $2.37 Billion Actos Settlement goes through

    http://www.prnewswire.com/news-releases/takedas-237-billion-actos-settlement-goes-through-says-lawsuitsettlementnewscom-300146011.html

    PR NEWS WIRE
    21 Sep 2015
    Share Share
    More than 96 Percent of Claimants Opt-In to ACTOS Resolution Program; Takeda Expects Resolution to Become Effective Once Submission Review Completed; Takeda Stands Behind ACTOS
    More than 96 Percent of Claimants Opt-In to ACTOS Resolution Program; Takeda Expects Resolution to Become Effective Once Submission Review Completed; Takeda Stands Behind ACTOS

    http://www.prnewswire.com/news-releases/more-than-96-percent-of-claimants-opt-in-to-actos-resolution-program-takeda-expects-resolution-to-become-effective-once-submission-review-completed-takeda-stands-behind-actos-300141851.html

    PR NEWS WIRE
    11 Sep 2015
    Share Share
    Could Common Diabetes Drugs Help Fight Leukemia?
    Could Common Diabetes Drugs Help Fight Leukemia?

    http://www.webmd.com/cancer/lymphoma/news/20150902/could-common-diabetes-drugs-help-fight-leukemia?src=RSS_PUBLIC

    Maureen Salamon WEBB MD
    02 Sep 2015
    Share Share
    Takeda’s $2.37 Billion Drug Accord Endangered
    Takeda’s $2.37 Billion Drug Accord Endangered

    http://www.bloomberg.com/news/articles/2015-08-13/takeda-s-2-37-billion-drug-accord-endangered-amid-low-sign-ups?

    Jef Feeley BLOOMBERG BUSINESS
    14 Aug 2015
    Share Share
    Takeda submits post-marketing Actos study that shows no link to bladder cancer
    Takeda submits post-marketing Actos study that shows no link to bladder cancer

    http://www.fiercepharmaasia.com/story/takeda-submits-post-marketing-actos-study-shows-no-link-bladder-cancer/2015-08-03

    EJ Lane FIERCE PHARMA ASIA
    04 Aug 2015
    Share Share
    New CEO Weber deals with Takeda's loss and promises brighter future
    New CEO Weber deals with Takeda's loss and promises brighter future

    http://www.fiercepharma.com/story/new-ceo-weber-deals-takedas-loss-and-promises-brighter-future/2015-05-15

    Eric Palmer FIERCE PHARMA
    15 May 2015
    Share Share
    Takeda to Acquire Select Portfolio from Neutec, Significantly Enhancing its Business in Turkey
    Takeda to Acquire Select Portfolio from Neutec, Significantly Enhancing its Business in Turkey

    http://www.takeda.com/news/2015/20150224_6916.html

    Press Release TAKEDA
    25 Feb 2015
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    veranova-m-2024-04-22

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search